MedPath

Slope and LabConnect Launch Revolutionary API Integration to Transform Clinical Trial Sample Management

8 months ago2 min read

Key Insights

  • Slope and LabConnect have introduced a groundbreaking bidirectional API integration combining Biospecimen360 platform with Laboratory Information Management System to enhance clinical trial data integrity.

  • The integration eliminates common errors in sample management, streamlines operations, and provides complete control over sample metadata, kit inventory, and shipping processes.

  • This innovative solution sets a new industry standard for real-time data exchange in clinical trials, offering mutual clients improved biospecimen lifecycle management capabilities.

In a significant advancement for clinical trial operations, Slope and LabConnect have unveiled a pioneering bidirectional API integration that promises to revolutionize biospecimen lifecycle management in clinical research.
The integration merges Slope's Biospecimen360 platform with LabConnect's Laboratory Information Management System (LIMS), addressing critical gaps in clinical trials and establishing new benchmarks for data integrity in sample management.

Enhanced Data Management Capabilities

The new solution tackles longstanding industry challenges by eliminating common errors associated with paper-based requisitions and resolving data entry delays typically seen with lab-specific portal e-requisitions. Users gain comprehensive control over sample metadata, kit inventory, and shipping processes, significantly improving the reliability of assay results.
"The integrity of assay results begins with the integrity of the sample," states LabConnect CEO Wes Wheeler. "Our integration with Slope ensures that every step of the biospecimen lifecycle is monitored, controlled, and documented with unparalleled accuracy. This level of data integrity has never before been achieved in our industry."

Operational Benefits and Efficiency

The integration delivers multiple operational advantages, including:
  • Reduced sample discrepancies
  • Decreased lab kit waste
  • Streamlined lab sample accessioning
  • Faster LIMS data reporting
  • Improved research site supply management

Strategic Impact on Clinical Research

Rust Felix, CEO of Slope, emphasizes the strategic significance of the integration: "This enhanced integration marks a significant advancement in biospecimen management. As part of our vendor-agnostic approach, Slope is committed to building an integrated lab ecosystem, with LabConnect as a key partner."
The solution is currently available to mutual clients of both companies, offering immediate access to improved operational efficiency and enhanced data accuracy. This transformation represents a significant step forward in clinical trial management, setting new standards for real-time data exchange and sample handling procedures.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.